Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|>99% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|>99% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|>99% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|>99% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|
HomeBlogRegulatory
Regulatory

DNA-Encoded Libraries Enable Tunable Cyclic Peptide Discovery

Researchers led by Petrov et al. in Nature Communications developed a dual-display ESAC library that provides three levels of conformational restraint in cyclic peptides: open, semi-closed, and fully closed. This 56 million-member library addresses purity and diversity issues in conventional DNA-encoded libraries. Selections against thrombin, streptavidin, and PLAP revealed target-specific preferences for peptide flexibility, guiding future designs.

VP

Volta Peptides

Editorial Team

May 12, 2026Updated June 19, 20263 min read
DNA-Encoded Libraries Enable Tunable Cyclic Peptide Discovery

Key Takeaways

  • A study by Petrov et al.
  • DNA-encoded chemical library technology builds large compound sets at low cost, but standard methods falter for cyclic peptides.
  • The Petrov team used dual-display ESAC on complementary DNA strands, HP5 and HP3.

DNA-Encoded Libraries Enable Tunable Cyclic Peptide Discovery

A study by Petrov et al. in Nature Communications presents a dual-display ESAC library with a two-step cyclization method. This approach achieves three levels of conformational restraint, open, semi-closed, and fully closed, in a single library of 56 million members. Such control allows screening vast chemical spaces for high-affinity cyclic peptide ligands suited to specific protein targets.

Challenges with Conventional Cyclic Peptide Libraries

DNA-encoded chemical library technology builds large compound sets at low cost, but standard methods falter for cyclic peptides. They suffer from low purity due to sequential split-and-pool steps on one DNA strand, where uneven reactions reduce final quality. Cyclization typically occurs in one step, yielding either too flexible linear forms or rigid cycles, missing intermediate conformations preferred by many targets.

Dual-Display ESAC Library Design

The Petrov team used dual-display ESAC on complementary DNA strands, HP5 and HP3. Each sub-library underwent two amino acid assembly rounds with purification before hybridization into heteroduplexes. Conformational states included open from DNA hybridization alone, semi-closed via N-terminal click chemistry, and fully closed with C-terminal bis-electrophiles or disulfides, each encoded separately.

Ensuring High Library Purity

Unlike typical DNA-encoded libraries, this method included HPLC purification and mass spectrometry after the first amino acid coupling for each sub-library. Purified sub-libraries then mixed for encoding and cyclization, preventing cumulative purity loss. Fully closed members showed molecular weights centered at 2000-4000 Da, aligning with common cyclic peptide drugs.

Thrombin Selection Results

Screening against thrombin enriched semi-closed cyclic peptides most. Validation off-DNA confirmed compound 1 had a KD of 609 nM in the clicked state, compared to 4.15 µM open. With varied C-terminal linkers, a medium-flexibility linker L1 yielded the best IC50 of 314 nM, outperforming flexible or rigid options, indicating preference for N-terminal constraint with C-terminal flexibility.

For researchers planning cyclic peptide studies, tools like the Peptide Glossary clarify terms such as click chemistry and conformational states.

Streptavidin Binding Preferences

Streptavidin selections also favored semi-closed peptides, with clicked formats showing strong affinity over open ones. Off-DNA tests with C-terminal linkers preserved binding only in the open C-terminus form, while cyclized versions lost activity. These peptides selected streptavidin over avidin and neutravidin, suggesting uses in reagent development.

PLAP Target Insights

Selections against PLAP enriched open conformation peptides unexpectedly. Analysis pointed to incomplete diazotransfer in synthesis, favoring free amine over azide forms. Resynthesized amine compounds outperformed azides and stayed open, showing PLAP prefers linear or partially constrained peptides over fully cyclized ones.

Implications for Peptide Research

This work proves the benefits of precise conformational control in screening. Targets displayed unique flexibility preferences, aiding rational cyclic peptide design. For projects, access to our Free peptide tools such as the Reconstitution Calculator and Dosage & Cycle Planner supports handling research compounds like those in BPC-157 Research Guide.

Fine-tuned libraries overcome purity and diversity limits in cyclic peptide discovery. Validated hits from such screens require resynthesis, structure-activity relationship studies, and property optimization for solubility, stability, and permeability. These steps demand expertise in synthesis and characterization to advance leads.


Looking for high-purity research peptides? Browse our catalog for HPLC-verified compounds.

CompoundPuritySizePrice
BPC-157 5mg>99%5mg$34.00
BPC-157 10mg>99%10mg$44.00

Browse Full Catalog →

Research Use Only. This article is provided for informational and educational purposes only. The compounds and topics discussed are intended solely for laboratory and scientific research. This content does not constitute medical advice, and Volta Peptides does not endorse or promote human consumption of any research compound.

More from the Blog

Regulatory

Peptide Drug Discovery: From Concept to Candidate

Peptide drug discovery integrates design, synthesis, and analytics to advance programs from early ideas to lead candidates. This approach addresses challenges where small molecules fall short, such as broad protein-protein interaction interfaces. Services cover hit identification, optimization for stability and potency, analytical verification, and scale-up for preclinical studies, supporting fields like metabolic disease and oncology.

May 12
Clinical Trials

Cyclo-zp80r Boosts NFC Orange Juice Preservation

A study in Foods shows the cyclic peptide cyclo-zp80r effectively combats Salmonella enterica and Listeria monocytogenes in NFC orange juice, reducing S. enterica counts by 3.6 Log CFU/mL in one day. It outperforms nisin, raises Galleria mellonella larvae survival from 0% to 40%, and remains stable at 121°C. Mechanisms include membrane disruption, ROS production, and DNA binding, though production faces purification challenges.

May 12
Regulatory

Peptide Library Design: Synthesis, Types, and Screening

Synthetic peptide libraries consist of small peptides made through chemical synthesis, with sizes calculated as 20^n using natural amino acids. Cyclic and linear variants support drug discovery, enzyme inhibition, and vaccine development. Screening methods like phage display and ELISA identify high-affinity binders from these libraries.

May 12
Regulatory

Oligonucleotide Drug Product Development and Manufacturing

Facilities support parenteral drug product development and manufacturing for oligonucleotide drugs from preclinical to commercial stages. Teams handle 85,000+ characterization tests yearly across 5 production lines with 70 million units annual capacity. Services cover advanced formulations like lipid nanoparticles, high potency injectables, and clinical supplies for phases I to IV.

May 12
Regulatory

Insulin-Like Growth Factors: IGF-1 and IGF-2 Explained

Insulin-like growth factors IGF-1 and IGF-2 play key roles in growth and development. IGF-1, stimulated by growth hormone, rises 2-3 fold during puberty and acts as both endocrine and local growth factors. IGF-2 supports fetal growth and binds distinct receptors, influencing proliferation and survival.

May 12
Science

best skin: Product Specifications, COA Verification & Research Status

Review of best skin peptide product specifications, analytical verification, storage, and research status for preclinical investigators.

Jul 28

Your Cart

Your cart is empty

Browse our catalog to add research compounds.